Document is current
Any future updates will be listed below
-
Authors
Sawada, Tomoyo https://orcid.org/0000-0002-2280-6238
Feltrin, Arthur S. https://orcid.org/0000-0002-1810-2203
Wang, Yanhong https://orcid.org/0000-0002-4527-0085
Araujo, Bruno https://orcid.org/0000-0003-0012-4217
McCord, Alejandra E.
Giles, Hunter H. https://orcid.org/0000-0002-2340-5444
Han, Shizhong https://orcid.org/0000-0002-5114-6742
Radulescu, Eugenia https://orcid.org/0000-0002-3924-768X
Chen, Qiang
Qamar, Bareera
R. Barbosa, André https://orcid.org/0000-0002-3261-984X
Jacomini, Ricardo S. https://orcid.org/0000-0002-4344-3560
Lorenzetti, Alan P. R. https://orcid.org/0000-0002-0291-248X
Dimitrova, Violeta https://orcid.org/0000-0002-5956-3559
Kaneva, Radka
Vladimirov, Vladimir https://orcid.org/0000-0002-0869-0937
Kleinman, Joel E. https://orcid.org/0000-0002-4210-6052
Hyde, Thomas M. https://orcid.org/0000-0002-8746-3037
Weinberger, Daniel R. https://orcid.org/0000-0003-2409-2969
Paquola, Apuã C. M.
Erwin, Jennifer A. https://orcid.org/0000-0002-6784-9290
-
Funding
Funding for this research was provided by:
Brain and Behavior Research Foundation
Maryland Stem Cell Research Fund (2023-MSCRFL-6185)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
- License Information
-
More Information
Article History
Received: 12 December 2024
Accepted: 24 November 2025
First Online: 20 December 2025
Competing interests
: J.E.K. is a member of a drug monitoring committee for an antipsychotic drug trial for Merck. D.R.W. serves on the scientific advisory boards of Sage Therapeutics and Pasithea Therapeutics. J.A.E. is a paid consultant for Aluco Biosciences and holds equity in the company. B.A. is now a full-time employee at GSK and whose current work is unrelated to the contents of this manuscript. His contributions to this manuscript were made while previously employed at the Lieber Institute for Brain Development. The other authors declare no competing interests.
